Nadhim Zahawi, the former chancellor, is joining an Israeli medical diagnostics group that is trying to transform the way infectious diseases are detected and managed.
Sky News understands that Mr. Zahawiwho has amassed a portfolio of roles since leaving frontline politics, will be named chairman of the Ador Diagnostics advisory board on Thursday.
His appointment should be announced by BATM, a London-listed company which holds 40% of Ador’s capital.
Ador’s president is Zvi Marom, founder of BATM and former first lieutenant in the Israeli Navy.
Last money: Landlord seeks £1,350 for room with unusual rules
Mr Zahawi, whose ministerial posts included overseeing the COVID-19 vaccination programme, was reportedly recruited to help Ador commercialize its research pipeline.
Ador claims its diagnostic panels can diagnose up to 100 different infectious disease pathogens, paving the way for faster, more accurate diagnosis and prescription of the appropriate antibiotic or treatment.
It recently began preclinical validation at a leading infectious disease research and treatment center in Rome, and plans to help more effectively diagnose other infectious diseases, including tuberculosis, meningitis, sepsis and sexually transmitted diseases. transmissible.
The former chancellor takes over as chair of Very Group, the online retailer which is expected to change hands in the coming months.
Read more on Sky News:
Surprise drop in inflation rate
Musk sued for the price he paid for Twitter shares
Backlash at major advertising company over four-day office rule
He has also played an active role in negotiations over the future ownership of the Daily Telegraph, whose economic owners are battling to land a sale worth more than £500m.
Mr. Zahawi considered his own bid for the paper and worked with advisers to Dovid Efune, the owner of the New York Post, who remains in talks to buy the right-wing title despite the end of a period of exclusivity.